HLB Biostep (278650) has reversed to a sharp decline, failing to sustain the momentum from the previous trading day's upper limit, while the Volatility Interruption (VI) device was triggered repeatedly during trading, showing significant volatility.

As of 11:20 a.m. on the 16th, HLB Biostep is trading at 2,205 won, down 200 won (8.32%) from the previous trading day.

On this day, HLB Biostep triggered a static VI three times from the early hours of trading. The first was triggered at 9:00:12 a.m. and lifted at 9:02:40 a.m., followed by a second VI from 9:04:16 a.m. to 9:06:19 a.m. Afterward, VI was triggered again at 11:16:45 a.m., with volatility continuing.

Earlier, the previous day, HLB Biostep hit the upper limit, helped by broad strength across HLB Group stocks. HLB Group saw buying interest flow into its affiliates broadly on news that some concerns related to U.S. approval for its liver cancer drug had been alleviated.

The market is closely watching whether HLB Biostep will continue its correction or attempt a rebound to recover its losses, amid expanding volatility following a short-term surge.

[※ This article is provided as reference material for investment decisions, and the ultimate responsibility for investment lies with the investor.]